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Whole genome methylation array 
reveals the down-regulation of 
IGFBP6 and SATB2 by HIV-1
Yinfeng Zhang1, Sai-Kam Li1, Kevin Yi Yang1,2, Minghua Liu1,2, Nelson Lee6, Xian Tang7, 
Hui Wang7, Li Liu3, Zhiwei Chen3, Chiyu Zhang4, Jianhua Wang4 & Stephen Kwok-Wing 
Tsui1,2,5
Nowadays, the knowledge in DNA methylation-mediated gene regulation has shed light on the 
understanding of virus-host interplay in the context of genome alteration. It has also been shown 
that HIV is able to change the DNA methylation pattern by DNA methyltransferases and such 
changes can be correlated with the progression of AIDS. In this study, we have investigated the 
relationship between genome-wide DNA methylation pattern and HIV infection using the methylated 
DNA immunoprecipitation - microarray method. A pair of monozygotic twins was recruited: one 
of the twins was infected with HIV while the other was not. Based on data from the microarray 
experiment, 4679 differentially methylated regions in the HIV positive subject with the significant 
peak values were identified. Selected genes were then validated in human T lymphocyte CEM*174 
cell line and HIV/AIDS patients by comparing with normal subjects. We found that IGFBP6 and SATB2 
were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/
AIDS patients while their promoters were predominantly hyper-methylated compared with normal 
controls. This study also provides a resource for the identification of HIV-induced methylation and 
contributes to better understanding of the development of HIV/AIDS.
After more than 30 years of HIV discovery, the pandemic acquired immunodeficiency syndrome (AIDS) 
has killed more than 35 million people worldwide. Despite the tremendous progress made in various 
aspects of the virus and its interplay with the host, the mechanisms underlying HIV pathogenesis remains 
poorly understood.
It is known that endogenous retroviruses in the human genome can be silenced epigenetically by the 
host DNA methyltransferases (DNMTs), including transcriptional repression of the proviral DNA, mod-
ifying the chromatin conformation, and epigenetically methylating the DNA at the enhancer/modulatory 
region1. Such hyper-methylation can also happen to the integrated HIV genome, which may explain the 
virus latency in chronic infections. In detail, the HIV long terminal repeats (LTR) was hyper-methylated 
at the CpG sites in the 5’-LTR but not the 3’-LTR. Moreover, De-methylation of CREB/ATF sites in 
the LTR has also been shown as a crucial step for the reactivation of latent HIV-1 genome in vivo2,3. In 
contrast, many eukaryotic viruses can interact with host cellular factors that contribute to the alteration 
of DNA methylation and eventually the downstream host gene transcription.
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It is well known that aberrant DNA methylation in cancer cell genomes may attribute to the effect of 
cancer-inducing viruses4. Intriguingly, several viral oncogenic proteins were found to be the interacting 
partners of cellular DNMTs and histone-modifying enzymes. Basically, mammalian CpG methylation is 
carried out by three active DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B5. DNMT1 has 
a higher preference for hemi-methylated DNA as the substrate. DNMT3A and DNMT3B are mainly 
regarded as de novo DNA methyltransferases, whose roles are critical in the dynamic DNA methylation 
process during embryogenesis and pathogenesis. However, it is also suggested that DNA methyltrans-
ferases do not work solely in maintenance or de novo methylation6–8.
Although HIV-1 is not regarded as a tumor virus, it was reported that HIV-1 triggers hyper-methylation 
of some host genes, e.g. HIV-1 infection of lymphoid cells could lead to the increase in DNMTs expres-
sion9–11, as well as the hyper-methylation and reduced expression of FOXP310, IFN-γ and p16INK4A12. 
In contrast to the myriad studies of HIV-1-induced differential gene expression, the genome-wide alter-
ations in DNA methylation induced by HIV-1 infection have not been described. To provide novel 
insights to HIV/AIDS pathogenesis, we identified the alterations of host genome methylation driven 
by HIV-1 using high-throughput technologies in this study. The effect of methylation on expression of 
selected genes was then validated at both transcriptional and translational levels. In summary, our results 
contribute to a comprehensive picture of epigenetic regulation of genes by HIV-1 in T cells.
Results
Diagnosis of HIV infection. A pair of 15-year-old female identical twins was recruited for this study. 
More clinical information of the twins could be found in the Materials and Methods section. The result 
of the fast screen test and Western blot confirmation showed that one of the twins was infected with 
HIV-1 while the other was not (Supplementary Figure. S1a and S1b). The CD3+ , CD4+ and CD8+ cell 
counts were given in Supplementary Table S1.
Confirmation of the zygosity of the twins. To validate the monozygosity of the twins, matches 
for short tandem repeats (STRs) were determined. Referring to the Supplementary Table S2, no genetic 
discrepancy between the HIV positive and negative subjects was observed in any of the 15 STR loci. 
Identical patterns in the two DNA samples at 15 STR markers were also shown in Supplementary Figure. 
S2. These results provided solid evidence to confirm the monozygosity of the twins.
Genes differentially methylated in the HIV+/- twins. Since the samples from HIV positive and 
negative subjects were hybridized onto the same chip, generated methylation peaks could be considered 
as unique peaks to one of the subjects, or designated as Differentially Methylated Regions (DMRs) if the 
peak value is above 3.0. Generally, two types of DMRs were identified: (1) methylated only in HIV+ twin 
and (2) methylated only in HIV- twin. In an effort to filter out false positives with an in-house script, if 
the methylation peak from either of the twins could be annotated to the same gene or region, the peak 
would be considered as the overlapped peak and therefore deleted from the DMRs list.
Using the NimbleGen array data analysis software, a total of 5919 and 2667 methylation peaks were 
identified in the HIV+ twin and HIV- twin, respectively. After filtering the overlapped peaks as men-
tioned above, there were a significantly larger number of DMRs unique to HIV+ twin (4679) and a 
significantly smaller number unique to HIV- twin (1753) (χ 2 test, P < 0.001, Fig. 1a).
In addition, by comparing the percentage of DMRs at different value ranges, we found another char-
acteristic feature of the genomic DNA methylation profiles between the twins. The result showed the 
significantly increased proportion of high methylation peaks (with the values above 3.5) in HIV+ twin 
than HIV– twin (χ 2 test, P < 0.001, Fig. 1b), especially at the ranges of 4.0-4.5, 4.5-5.0 and above 5.0, the 
DMR proportion of HIV+ twin were nearly twice as high as that in her normal sibling. In order to deter-
mine the proportion of DMRs in different genomic regions, the numbers of DMRs were compared in the 
promoter (defined as 1000 bp from the TSS), primary transcript and intergenic regions according to the 
rules mentioned in the section of Materials and Methods based on the Nimblegen microarray design. In 
both twins, >50% of the DMRs were located in promoter regions (Fig. 1c). Moreover, DMRs in promoter 
regions were higher in HIV+ twin while DMRs in other genomic regions of both subjects were similar.
As predicted by the software of Idiographica V 2.113, several chromosomal loci displayed positional 
enrichments of DMRs in HIV+ twin by considering the length of chromosome, such as chromosome 
17, 19 and 22 (Supplementary Figure. S3).
Functional profiling of genes differentially methylated in HIV+/- twins. To determine whether 
there were any common categories in the identified methylated genes, we performed the gene ontology 
functional classification. Considering that the distance of methylated CpG islands from transcription 
start sites would affect the gene expression regulation14,15, we divided all DMR-associated genes with 
peak value >3.0 based on their genomic locations of DMRs into three different groups - non-CpGi pro-
moter, CpGi promoter and primary transcript. As shown in Table 1, biological process, molecular func-
tion and cellular component categories are significant GO terms in the CpGi promoter group in HIV+ 
twin. Within the category of biological process, the most significant functional terms were “regulation of 
transcription” in the HIV+ twin and “regulation of neuron apoptosis” in the HIV- twin. All statistically 
significant functional GO categories (P < 0.001) in other groups are listed in Supplementary Table S3. 
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When KEGG pathway analysis was used to further analyze DMRs in CpGi-promoter region of HIV+ 
twin, pathways involved in ribosome, pyrimidine metabolism and steroid biosynthesis were significantly 
enriched (P < 0.05) (Table 1).
Validation of the MeDIP/ microarray results in human CEM*174 T lymphocyte cell line and 
HIV/AIDS patients. Next, we selected 25 hyper-methylated target genes in HIV+ twin based on 
their peak values and results of GO classification for validation in T lymphocyte cell line by real-time 
PCR. Our results showed that the transcriptional level of most of the target genes (18/25) were decreased 
by more than 50% in the HIV+ twin (Fig. 2). In particular, some genes exhibited a bigger decrease in 
expression level, such as IGFBP6 (6.72 fold) and SATB2 (3.99 fold).
For further verification, IGFBP6 and SATB2 from the 25 genes were selected because of their high 
peak values (SATB2 = 5.55, IGFBP6 = 5.08), greater fold changes at the transcriptional level and the 
potential relationship with HIV infection according to literatures16–18. The western blotting result showed 
that the alterations could also be observed at the protein level. The amounts of both target proteins have 
been decreased significantly upon the HIV infection (Fig.  3a). The β -actin was used as the internal 
reference.
Afterwards, we examined the methylation status of the CpGi in promoter regions of IGFBP6 and 
SATB2 in both twins and HIV-infected/uninfected CEM*174 cell lines using bisulfite sequencing. Each 
row from the Fig. 3b,c represents an individual clone with solid circle representing the methylated CpG 
site whereas open circle as the unmethylated CpG site. The result suggested that the promoter region 
of IGFBP6 and SATB2 in HIV+ twin was hyper-methylated. This hyper-methylation was absent in the 
HIV- twin. Consistently, the hyper-methylation pattern could also be observed in the T cell line upon 
HIV infection.
In addition, 8 HIV/AIDS patients and 8 normal subjects were recruited to further validate this finding. 
The result showed that both genes were down-regulated in the group of HIV/AIDS patients at the tran-
scriptional level. After normalization by the β -actin, the expression level of IGFBP6 was down-regulated 
Figure 1. Data analysis of methylation microarray. (a) The differential methylation regions (DMRs) in 
both twins. The red bar indicated the overlapped methylation regions while the blue bar indicated the 
differentially methylation regions. A total of 4679 DMRs were found in HIV positive twin and 1753 DMRs 
in the HIV negative twin. (b) Numbers of high value DMRs in the genome-wide DNA methylation profiles 
in both twins at different value range. It was assumed that high value DMRs have the peak values over 3.0. 
(c) Numbers of DMRs at different distance range from transcription start sites in both twins. DMRs were 
divided into 3 categories according to their location from the genes they were mapped to. Numbers in the 
parentheses indicate the percentage.
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by 65.9% in HIV/AIDS patients relative to normal controls (Fig. 4a, P = 0.04, one sided Mann-Whitney 
U test) while SATB2 was down-regulated by 57.1% (Fig. 4b, P = 0.027). In addition, Fig. 4c,d showed the 
methylation status of these two genes in both patients and normal subjects. In the promoter region of 
IGFBP6, 4 out of the 8 patients (50%) and none of the normal subjects (0%) were methylated while in 
that of SATB2, the promoter region of 6 patients (75%) and one normal subject (12.5%) were methylated.
To reduce the impact caused by other factors such as sex, age and antiretroviral reagents on meth-
ylation and differential expression, we have further recruited 20 HIV infected male patients with sim-
ilar viral load who did not receive any antiretroviral therapy and 20 normal subjects with age and sex 
matched (The clinical information was shown in Supplementary Table S6). According to the distribution 
of ages, samples have been divided into two groups: age under 34 years (8 normal subjects vs 12 HIV/
AIDS patients) and age between 34 and 60 years (12 normal subjects vs 8 HIV/AIDS patients). Consistent 
with our previous results, we found that the relative expression levels of both IGFBP6 and SATB2 were 
low in all groups of HIV/AIDS patients compared with normal groups. Normalized by the β -actin, in 
the group with “ age under 34 years”, “age between 34 and 60” and “all samples”, the expression level of 
IGFBP6 was down-regulated by 53.7%, 42.4% and 47.8%, respectively, in HIV/AIDS patients relative to 
normal controls (Fig. 5a, P < 0.001, two sided Mann-Whitney U test) while SATB2 was down-regulated 
by 87.8%, 95.9% and 94.3%, respectively (Fig. 5b, P < 0.001). Furthermore, MSP experiment were also 
performed in HIV infected patients with age between 34 and 60 years. Due to the limitation of samples, 
another batch of 10 male normal subjects with age matched has been recruited for the comparison. 
Figure 5c,d showed the methylation status of these two genes in both patients and normal subjects. In 
the promoter region of IGFBP6, 3 out of the 10 patients (30%) and 1 out of the normal subjects (10%) 
were methylated while in that of SATB2, the promoter region of 6 patients (60%) and 3 normal subject 
(30%) were methylated. Therefore, our results indicated that HIV infection was involved in the differen-
tial methylation and transcriptional regulation of IGFBP6 and SATB2.
To further validate the above observation, we have recruited 5 HIV infected subjects with multiple 
visits. For each patient, a blood sample with a very high viral load (>20,000 copies/ml) was collected 
during the first visit and then another sample with a very low viral load (<500 copies/ml) was taken 
during the second visit (Supplementary Table S6). Since these paired samples were collected from the 
same subject, the results would reflect the relationship between the viral load and our target genes. We 
found that 80% (4 out of 5) of samples with high viral load had a lower expression of IGFBP6 and SATB2 
when compared to samples with low viral load (Fig. 6a,b). Meanwhile, the MSP experiment showed that 
Ontology type Term p-Value
GOTERM_BP_
FAT regulation of transcription 5.50E-04
cellular macromolecular complex subunit organization 6.10E-04
actin polymerization or depolymerization 9.00E-04
GOTERM_CC_
FAT non-membrane-bounded organelle 1.20E-08
intracellular non-membrane-bounded organelle 1.20E-08
cytosol 3.60E-06
intracellular organelle lumen 1.20E-05
membrane-enclosed lumen 1.70E-05
organelle lumen 3.20E-05
microtubule cytoskeleton 3.80E-05
protein-DNA complex 2.10E-04
ribonucleoprotein complex 7.30E-04
nuclear lumen 9.20E-04
GOTERM_MF_
FAT transition metal ion binding 3.40E-06
DNA binding 8.20E-06
zinc ion binding 1.60E-05
KEGG_
PATHWAY hsa03010:Ribosome 7.85E-03
hsa00240:Pyrimidine metabolism 1.66E-02
hsa00100:Steroid biosynthesis 4.04E-02
Table 1.  Annotation analysis of DMRs in CpGi-promoter region from HIV+ twin. a. Detailed data are 
shown in Supplemental Table S3. b. Ontology types of BP, CC and MF represents biological process, cellular 
component and molecular function. KEGG represents KEGG pathway database.
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3 out of 5 subjects for the SATB2 and 2 out of 5 subjects for IGFBP6 were consistent with our previous 
findings (Fig. 6c).
Determination of DNMTs expression in HIV infected cells. It has been reported that HIV can 
change the expression of DNMTs, resulting in the alterations of DNA methylation across the genome. 
Therefore, we have also checked the differential expression of DNMT1, DNMT3A and DNMT3B in 
CEM*174 T cell line during HIV infection. The results showed that after viral infection, both DNMT1 
and DNMT3A displayed a significant increase in expression (P < 0.005). However, DNMT3B showed a 
relatively higher expression (P = 0.01) (Fig.  7a). Therefore, the DNMT3B was chosen for further anal-
ysis. As expected, the western blotting data confirmed the real-time PCR results - the protein level of 
DNMT3B was greatly increased in HIV-infected cells than the control (Fig.  7b), which indicated that 
the HIV may affect DNMT3B and up-regulate its expression to change the DNA methylation pattern 
across the genome.
Discussion
Nowadays, the genome-wide DNA methylation study was greatly facilitated by the use of deep sequenc-
ing or gene tiling arrays. However, there was very limited number of studies on DNA methylation 
induced by HIV in contrast to the importance of HIV in scientific/biomedical research. One major 
obstacle was the lack of an appropriate model. It has been well known that the epigenetic alteration is 
regulated by both genetic and environmental factors, which mean individual variations are enormous 
among individuals19,20. Therefore, finding an ideal model with individuals having nearly identical genetic 
background would be very important to HIV methylation research. Due to the ethical consideration and 
practical situation, it is difficult to obtain samples from the same person before and after HIV infection. 
One of the solutions is the use of SIV in non-human primate model. However, because of the genetic 
variations between SIV and HIV as well as the different epigenetic regulation patterns in human and 
monkey, the results generated could not totally reflect the real situation in HIV patients. In this study, the 
solution we explored is the model of identical twins. Twins have been commonly recruited in scientific 
research because of the perfectly matched genetic background and very similar living environment21,22. 
Furthermore, in the context of epigenetic variations, it has been shown that monozygotic twins have 
similar methylation content in their genome, in contrast to that of dizygotic twins and other unrelated 
Figure 2. Relative transcript level of 25 genes in CEM*174 T cell line before and after HIV infection. 
The mRNA expression level of selected genes were determined and normalized with β -actin mRNA. Results 
were given as fold change in mRNA expression with ± SD. Independent experiments were repeated three 
times.
www.nature.com/scientificreports/
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Figure 3. The expression level and methylation status of 2 target genes in CEM*174 T cells. (a) Western 
blotting result of IGFBP6 and SATB2 in HIV infected/uninfected CEM*174 cell lines. Full-length blotting 
images are presented in Supplementary Figures. The bisulfite sequencing result of (b) SATB2, (c) IGFBP6 in 
HIV infected/uninfected CEM*174 cell lines and both twins were shown. Solid circle represented methylated 
CpG islands; Open circle represented unmethylated CpG islands.
www.nature.com/scientificreports/
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Figure 4. Comparison of relative expression level and methylation status of IGFBP6 and SATB2 
between 8 HIV/AIDS patients and normal subjects. The mRNA expression levels of IGFBP6 (a) and 
SATB2 (b) were analyzed in 8 HIV/AIDS patients and 8 normal people. Round dots represent normal 
control; Rectangle dots represent HIV/ AIDS patients. The y-axis is plotted on a logarithmic scale. * P < 0.05, 
Mann-Whitney U test. Methylation status of IGFBP6 (c) and SATB2 (d) were checked by MSP. From left to 
right lanes in the HIV/AIDS patient panel, bands represent the methylated PCR products from patients 1 
to 8. M, PCR for CpG-methylated DNA; UM, PCR for CpG-unmethylated DNA. Fully uncut gel images are 
shown in Supplementary Figures.
www.nature.com/scientificreports/
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persons generally23–25. Therefore, by comparing the epigenetic regulation between monozygotic twins, 
the genetic influences on epigenetic changes are eliminated while the variations could be attributed to 
exogenous factors such as viral infection. In this study, comparing to her healthy sibling and the reference 
range of healthy population from 3 different districts in China: Beijing, Hong Kong and Shanghai26–28, 
the HIV+ twin had a significantly reduced count of CD4+ cells of < 350 cells/microliter (Supplementary 
Table S1) and an abnormal CD4/CD8 cell ratio, suggesting that the HIV+ subject was at the moderate 
advanced stage of AIDS. The model is also reliable because the HIV+ twin has not received any antiret-
roviral therapies, meaning that there were persistent interactions between the virus and the host as well 
as reduced number of confounding factors on methylation.
In our study, the MeDIP method followed by promoter CpGi microarray analysis was utilized to 
identify DMRs. Since this is a pioneer study without previous references, more conservative criteria were 
applied to identify and eliminate overlapped methylated DMRs. Although the total number of DMRs 
may be underestimated because DMRs with low CpG density could be missed by MeDIP29, almost 5000 
DMRs in HIV+ twin and 1800 DMRs in HIV– twin were identified. Due to the limited amount of blood 
samples, the PBMCs were analyzed and this practice is common in HIV research. To justify the use of 
PBMCs, we have overlapped the detected DMRs with loci exhibiting CD4 T cell-specific methylation 
using a bioinformatics approach together with literature search. Briefly, 601 from 1887 genes differen-
tially methylated in CD4 T cells30–38 were overlapped with our databases of DMRs. Our results showed 
that 395 genes and 206 genes were found in the lists of hyper-methylated DMRs from the HIV positive 
twin and HIV negative twin, respectively. This implies that 8.44% and 11.75% of DMRs in the HIV+ 
twin and HIV- twin are CD4 T cell type specific (Supplementary Table S7). Moreover, to estimate the 
proportion of DMRs associated with HIV infection in our database, we have overlapped the detected 
Figure 5. Decreased expression of target genes between 20 HIV/AIDS patients with similar viral load 
and 20 age- and sex-matched normal subjects. All HIV/AIDS patients did not receive any antiretroviral 
therapy. The mRNA expression levels of IGFBP6 (a) and SATB2 (b) were analyzed in 3 groups: age under 
34 years (8 normal subjects vs 12 HIV/AIDS patients), age between 34 and 60 years (12 normal subjects vs 
8 HIV/AIDS patients) and all samples (20 normal subjects vs 20 HIV/AIDS patients). Round dots represent 
normal control; Rectangle dots represent HIV/AIDS patients. The y-axis is plotted on a logarithmic scale. 
*** P < 0.005; ** P < 0.01; * P < 0.05, Mann-Whitney U test. Methylation status of IGFBP6 (c) and SATB2 
(d) were checked by MSP. M, PCR for CpG-methylated DNA; UM, PCR for CpG-unmethylated DNA. Fully 
uncut gel images are shown in Supplementary Figures.
www.nature.com/scientificreports/
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DMRs with reported loci exhibiting different methylation in PBMCs of other MZ twins without HIV 
infection using a bioinformatics approach together with literature search. Our results showed that 182 
(142 genes in HIV+ twin and 40 genes in HIV- twin) out of the 1458 genes in our databases of DMRs 
are differentially methylated in MZ twin pairs23,39–44 in the literature. This implied that only 3.0% and 
2.3% of DMRs in our HIV+ twin and HIV- twin were overlapped with DMRs known to be variable in 
MZ twin pairs (Supplementary Table S7). Based on the results, we have the confidence that authentic 
Figure 6. The comparison of expression level and methylation status of target genes in HIV infected 
patients with high and low viral load. The mRNA expression levels of IGFBP6 (a) and SATB2 (b) were 
analyzed in 5 HIV infected subjects with different viral load. * P < 0.05, Paired Student T test. Data represent 
means ± SD from at least 2 independent experiments. HIV VL < 500 indicated that the sample was collected 
when the viral load of the subject was lower than 500 copies/ml; HIV VL > 20,000 indicated the viral load 
was higher than 20,000 copies/ml. Methylation status of IGFBP6 and SATB2 (c) were checked by MSP. M, 
PCR for CpG-methylated DNA; UM, PCR for CpG-unmethylated DNA. If the viral load of the sample 
was lower than 500 copies/ml or higher than 20,000 copies/ml, it would be termed as “HIV − ”or “HIV + ”, 
respectively. Fully uncut gel images are shown in Supplementary Figures.
Figure 7. Determination of DNMTs expression. (a) Relative transcript levels of DNMT1, DNMT3A 
and DNMT3B (*** P < 0.005; ** P < 0.01; * P < 0.05; Paired Student T test) and (b) Western blot result 
of DNMT3B in HIV infected and uninfected CEM*174 cell lines. Data represent means ± SD from 3 
independent experiments. Full-length blotting images are presented in Supplementary Figures.
www.nature.com/scientificreports/
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and significant number of DMRs from the MZ twins associated with HIV infection could be captured 
in this study for validation in subsequent experiments.
Moreover, our results showed that many more methylated DMRs as well as higher average peak values 
were found in HIV+ twin when compare with HIV- twin, implying that the HIV infection would cause 
the increase of global methylation level. This finding is consistent with several reports mentioned that 
HIV infection triggers the up-regulation of DNA methyltransferases. For example, an up-regulation of 
DNMT1 could be triggered by the expression of non-structural HIV genes, including nef, tat and rev, in 
an in vitro HIV acute infection model9,11. In addition, up-regulation of DNMT3B upon HIV infection 
has been previously demonstrated10,45. It is notable that similar phenomenon has also been observed in 
our study, although the detailed mechanism deserves further investigation. Another interesting result 
is the chromosomal locations of DMRs in HIV+ twin. According to our bioinformatics analysis, posi-
tional enrichments of DMRs were located in chromosomes 17, 19 and 22. It has been proposed that 
HIV prefers to integrate into actively transcribed genes for efficient expression of viral genome rather 
than integrating randomly46. All three chromosomes with high gene density have been reported to be 
preferred for HIV integration47,48. Therefore, one plausible explanation of the phenomenon was that the 
host utilizes the DNA methylation to suppress the HIV propagation.
In both subjects, >50% DMRs were located in promoter regions while more than 30% of them were 
located in CpGi promoter regions. It was lower than the proportion of promoter CpGs represented in 
NimbleGen array partly because of our relatively conservative screening criteria. In addition, because the 
input and control samples were both methylated DNA fragments captured by antibody from HIV+ and 
HIV- twins, same methylated regions may not be displayed in the subsequent analysis. When DMRs were 
divided into different groups according to their genomic location, we found that significant differences 
could be found in many important biological processes when the CpGi promoter groups of HIV+ and 
HIV- twins were compared. Moreover, it is interesting that the steroid biosynthesis pathway was iden-
tified by KEGG in the DMRs located in CpGi promoter region of HIV+ twin (Table  1) because HIV 
infection has been reported to contribute to dyslipidaemia49 and some steroid hormones, like estrogens, 
have been described to reduce the HIV infection50. Whether the disruption of steroid biosynthesis by 
DNA methylation was a strategy exploited for HIV replication deserves future investigation.
Although MeDIP-NimbleGen microarray is one of the powerful methods to detect the regional meth-
ylation changes at a genome-wide scale, some limitations still exist. One of the concerns is that the 
MeDIP-NimbleGen microarray method tends to find the methylated regions with CpG rich content. 
Despite of the fact that the MeDIP-microarray method can provide more precise result in high CpG 
region29, the differentially methylated regions in low CpG regions may be lost. Potential impacts can 
also be inferred from the complicated correlations between DMRs and their impact on gene expression. 
One of the situations is the usage of alternative promoter. Since the alternative promoter may be utilized 
by different splicing isoforms, DMR located in the promoter of one isoform could not exert regulation 
effect on other isoforms with alternative promoter. Furthermore, multiple DMRs can be correlated with 
one gene at the same time. All these limitations highlight the importance to critically verify the results 
from MeDIP-microarray. Therefore, our microarray results were further confirmed in the CD4+ T lym-
phocyte cell line and recruited HIV/AIDS patients. For validation, the most distinguished genes from the 
DMRs list with high peak values were focused so as to minimize the possibility that the methylation was 
caused by individual variations. The results from CEM*174 T cell line showed that most of the selected 
genes were down-regulated. In addition, we also observed the down-regulation of IRAK4 which has been 
previously reported to be methylated during HIV infection51. This finding can serve as a positive control 
of our study. To further verify our result, we selected 2 representative genes with high peak values and 
greater alterations at the transcriptional levels. One of the reasons for the selection was that a few articles 
showed their potential association with HIV, although both genes have not been reported to play a role 
in the process of viral infection. SATB2 is the modulator of Δ Np63α 16, which may interact with HIV-1 
Tat protein17. IGFPB6 is a member of the IGFBP super-family, whereas the levels of IGFBP1, 2 and 3 have 
been observed to vary in patients with HIV/AIDS18. As expected, both target genes were down-regulated 
at the protein level in T cell line upon HIV infection while the BSP result showed that their promoter 
regions were hyper-methylated. It was consistent with the fact that the methylation peaks annotated to 
IGFBP6 and SATB2 from the chip were located in promoter regions. The promoter methylation of these 
two genes was also demonstrated by the BSP result of the twins. Furthermore, combined with the reduced 
mRNA level and the MSP results in three cohorts of HIV/AIDS patients compared with normal control, 
our results indicated that HIV infection was involved in the differential methylation and transcriptional 
regulation of IGFBP6 and SATB2. More importantly, the expression of these two genes were potentially 
associated with the viral load of HIV. This finding has not been reported before and these two genes 
may be good targets for future HIV/AIDS research. Taken together, the efficacy of the MeDIP-microarray 
approach for the identification of genes epigenetically regulated by HIV-1 has been well demonstrated in 
this study and identified DMRs could be applied to a wide range of HIV/AIDS research.
To our knowledge, this is the first report discussing the genome-wide DNA methylation associated with 
HIV-1 infection in monozygotic twins. Our findings contribute to the understanding of HIV-associated 
global methylation and provide a draft of HIV epigenome.
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Methods
Ethical Statement. The study was approved by the Institutional Ethic Committee of Jiangsu University, 
China and the Institutional Review Board of the Chinese University of Hong Kong. All experiments were 
carried out in accordance with the ethical guidelines concerning the use of human research participants 
approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research 
Ethics Committee (CREC Ref. No: CRE-2012.416). Written informed consent was obtained from all 
subjects involved in this study for the collection of samples and subsequent analysis.
Human blood samples. A pair of 15-year-old female identical twins was recruited for further study 
based on fast screening test utilizing the Colloidal Gold kit and HIV Blot 2.2 Western Blot confirmation 
assay (Genelabs). The cell-counts were determined by FACS counting using BD Trucount tubes (BD 
Biosciences). Both twins were high-school students while none of them was drug-user. The infection 
was a clinical accident when one of the twins was injected with contaminated needle. The HIV positive 
twin has not received any antiretroviral therapy. Afterwards, the two batches of blood samples from 
8 and 20 HIV/AIDS patients were collected from the Prince of Wales Hospital and Shenzhen Third 
People’s Hospital while the samples of healthy subject were obtained from Hong Kong Red Cross Blood 
Transfusion Service or Prince of Wales Hospital, respectively. The blood samples from 5 HIV infected 
patients with high viral load and low viral load were collected from the Shenzhen Third People’s Hospital. 
The clinical records of normal subjects could not be disclosed because of the privacy protection while 
all records of HIV/AIDS patients were shown in the Supplementary Table S6. The PBMCs were sepa-
rated from the EDTA-blood collected from the blood samples. Total genomic DNA was extracted from 
PBMCs using QIAamp DNA Mini Kit (QIAGEN) according to the manufacturer’s instructions. QIAamp 
RNA Blood Mini (QIAGEN) kit was used to extract total RNA from the HIV/AIDS patients and normal 
subjects.
In addition, to verify whether the twins were actually monozygotic, their genomic DNA was analyzed 
by STR PCR with the Applied Biosystems AmpFlSTR® Identifiler® PCR Amplification Kit examining 
15 + 1 loci.
Immunoprecipitation of cytosine methylated DNA (MeDIP) and amplification of DNA. 
Immunoprecipitation of methylated DNA was performed using the Methylated-DNA IP Kit (Zymo 
Research). In order to acquire enough DNA for microarray, the immunoprecipitated methylated-DNA 
was amplified using GenomiPhi V2 kit (GE Medical Systems)52.
DNA labelling and hybridization. DNA labelling and hybridization was performed according to 
NimbleGen’s protocol. The immunoprecipitated CpG-methylated DNA from HIV positive subject (test) 
and from HIV negative subject (input control) were labelled with Cy5 and Cy3. The DNA samples were 
then co-hybridized onto NimbleGen Human DNA Methylation 2.1M Deluxe Promoter Array. Raw data 
of methylation microarray were deposited at GEO under accession number GSE68028.
Data acquisition and processing. The data scanning and collections were performed using MS 200 
Microarray Scanner and MS 200 Data Collection Software. Finally, the result of microarray was analyzed 
by DEVA version 1.2.1 software (Roche, Nimblegen) using default parameters. After the extraction of 
signal intensity data from the scanned images, the results of log2 ratios, P-score, and peaks were pro-
cessed and obtained. Log2 ratios represent the ratios of test signal of immunoprecipitated DNA from HIV 
positive subject to the input control signal ratio of immunoprecipitated DNA from HIV negative subject 
co-hybridized to the array. From Log2 ratio data, a 750bp fixed-length window was placed around each 
consecutive probe followed with Kolmogorov-Smirnov (KS) test, and the resulting score called P-score 
was the -log10 P-value for each probe. Finally, the methylation peak data was generated from the P 
score data through merging consecutive probes with the following default conditions: minimum cut-off 
p-value 2.0, maximum 500 bp spacing and minimum of two probes per peak.
Microarray data analyzing. The methylation peaks were mapped to features (transcription start sites, 
primary transcripts, CpG islands, and other tiled regions) using DEVA software v.1.2.1. Furthermore, to 
categorize the methylation peaks, the location was defined in context of a gene with the annotation 
data of promoters, CpG island regions, primary transcripts as well as their genome coordinates from 
NimbleGen based on UCSC 2010 reference genome hg19. Each methylation peak could be classified 
into six different categories according to their locations using an in-house script: Promoter region with 
CpG Island; Promoter region without CpG Island; Intergenic region with CpG Island; Intergenic region 
without CpG Island; Primary transcript region with CpG Island; Primary transcript region without CpG 
Island. In detail, the promoter region was defined as the 1-kb region flanking each side of the transcrip-
tion start site (TSS); the intragenic region of primary transcript was defined as the region inside a gene 
excluding the promoter; the intergenic region was defined as the region 2 kb away from any annotated 
genes. Depending on whether the methylation peak located in the CpG island region, all three groups 
were further categorized in with or without CpG island sub-groups.
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Gene function annotation and pathways analyses. Gene functions were annotated using The 
Database for Annotation, Visualization and Integrated Discovery (DAVID) 53. We have adapted the 
official symbols for the gene names and annotation sources GO: BP (biological process), CC (cellular 
component) and MF (molecular function) for the pathway analyses. Kyoto Encyclopedia of Genes and 
Genomes (KEGG) were used for pathways analyses.
Chromosomal diagrams with the locations of differentially methylated regions. The differen-
tially methylated regions from both HIV infected and uninfected twins were plotted in the chromosomal 
maps by Idiographica V 2.113.
Virus, cell culture and infection. HIV-1NL4-3 was generated by transfection of plasmid pNL4-3 
into HEK 293T cell. The CEM*174 cell line was infected with HIV NL4-3 virus at a MOI = 1. Five days 
post-infection, CEM*174 T cells were harvested for the further study. Viral replication was monitored 
by p24 ELISA kit.
Extraction of genomic DNA, total RNA and protein from cell lines. Genomic DNA, total RNA 
and proteins from HIV infected and non-infected CEM*174 cell lines were extracted separately. Genomic 
DNA and total RNA were extracted by QIAamp DNA Mini and QIAamp RNA Blood Mini (QIAGEN) 
kit separately. Total protein was extracted by lysing the cells in RIPA buffer with protease inhibitor and 
then centrifuged.
Determination of relative transcription level by real-time PCR. The mRNA relative expression 
was determined by real-time PCR with SYBR® Green PCR Master Mix (Applied Biosystems) in triplicate. 
After normalization with the housekeeping gene ACTB, the relative expression level of the target genes 
was calculated by Δ Δ Ct method. Primers used in real-time PCR were listed in Supplementary Table S4
Western blot analysis. Monoclonal antibodies targeting IGFBP6 (ab135606), SATB2 (ab51502) 
and DNMT3B (ab13604) were obtained from Abcam and used at 1 μ g/ml of 5% non-fat milk with 
0.1% Tween-20 (USB). Mouse antibody conjugated with horse-radish peroxidase (HRP) for β -actin was 
obtained from Santa Cruz (sc-47778) and used at 1:5,000 dilutions. Goat anti-mouse-HRP and Goat 
anti-rabbit-HRP was obtained from Santa Cruz (sc-2031 and sc-2030) and used at 1:3,000 dilution.
Bisulfite treatment, methylation-specific PCR (MSP) and bisulfite-sequencing PCR 
(BSP). Primers used in the MSP and BSP were listed in Supplementary Table S5. The methylation 
status of the target genes in the twins and CEM*174 cell lines were determined by bisulfite sequencing 
using EZ DNA Methylation-Gold™ Kit (Zymo Research) as instructed. The target regions were amplified 
using Taq polymerase (Invitrogen) cloned into T-vector (Invitrogen) and sequenced as instructions. The 
resulting sequences of the bisulfite treated DNA were aligned with the reference genome and reported 
in the form of “lollipop” diagram by BiQ Analyzer54. Methylation specific PCR was performed to ana-
lyze the methylation status of the target genes in the HIV/AIDS patients and normal subjects. Standard 
Human WGA Non-Methylated DNA (Zymo Research) were used as positive control in PCR for unmeth-
ylated CpGs and negative control in PCR for methylated CpGs; while conversely, Standard Human WGA 
Methylated (Zymo Research) were used as negative control in PCR for unmethylated CpGs and positive 
control in PCR for methylated CpGs
Statistical analyses. Statistical analysis was performed using by SPSS (SPSS, Chicago, IL, USA). 
Values of P < 0.05 were considered statistically significant. The specific statistical tests used were intro-
duced individually. GraphPad Prism5 and Microsoft Excel were used to make the figures.
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